D Belpomme

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

Graham J. Kemp, Peter S. Rose, John R. Lurain et al. · Journal of Clinical Oncology · 1996 · 467 citations

Advanced epithelial ovarian cancer: 1993 consensus statements

Darlene Allen, J. Baak, D Belpomme et al. · Annals of Oncology · 1993 · 185 citations · Full text

Gynecological Surgery, Medicine, Gynecology +4

Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis

Marie‐Julie Nokin, Florence Durieux, Paul Peixoto et al. · eLife · 2016 · 127 citations · Full text

Metabolic Remodeling, Yap-mediated Tumor Growth, Cancer Biology +17

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

D Belpomme, S. Gauthier, Éric Pujade-Lauraine et al. · Annals of Oncology · 2000 · 115 citations · Full text

Breast Oncology, Oncology, Medicine +7

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.

J. L. Misset, Mario Di Palma, Mayte Delgado et al. · Journal of Clinical Oncology · 1996 · 104 citations